Screener
Sabra Healthcare SBRA Restricted Cash
Restricted Cash at other companies
Other financials
Where this comes from
Reported directly by Sabra Healthcare in its filing.
Tagged under the XBRL concept us-gaap:RestrictedCashAndCashEquivalents.
The source filing: Sabra Healthcare’s 10-Q, filed April 29, 2026.
- Filed
- Apr 29, 2026, 4:06 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001492298-26-000012
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Loans receivable and other investments, net | 432,909 | 434,100 |
| Investment in unconsolidated joint ventures | 116,537 | 118,166 |
| Cash and cash equivalents | 116,530 | 71,537 |
| Restricted cash | 6,921 | 6,603 |
| Lease intangible assets, net | 67,414 | 65,321 |
| Accounts receivable, prepaid expenses and other assets, net | 148,088 | 111,292 |
| Total assets | $5,591,190 | $5,493,396 |
| Liabilities |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Sabra Healthcare's restricted cash?
- Sabra Healthcare (SBRA) reported restricted cash of $6.92M in Q1 2026.
- How has Sabra Healthcare's restricted cash changed year-over-year?
- Sabra Healthcare's restricted cash increased by 10.8% year-over-year, from $6.24M to $6.92M.
- What is the long-term trend for Sabra Healthcare's restricted cash?
- Over 5 years (2020 to 2025), Sabra Healthcare's restricted cash has grown at a 0.5% compound annual growth rate (CAGR), from $6.45M to $6.6M.
- What does restricted cash mean?
- Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.
Ask your AI about Sabra Healthcare's restricted cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude